ORANGE Infinity Holdings (ORANGEinfinity) is an international investment business with investments in the Technology, Healthcare, Distribution and Beauty product sectors.
ORANGE Infinity Holdings (ORANGEinfinity) is an international investment business based in Sydney. With investments in the technology, healthcare, distribution and beauty product sectors, the firm has four main units: OI Health, OI Technology, OI Retail, and OI distribution, all of which are supported by OI Treasury Services, which manages the group’s liquidity. The board now includes Darren Dye as CEO and Managing Director and Ms Xing Mao as Executive Director.
ORANGEinfinity was set up in 2017 as part of a broader new investment vehicle by founder Xing Mao. By early 2023 ORANGEinfinity had completed the acquisition of the AMA Medical Products to add to its portfolio. ORANGEinfinity has plans to invest in both its UK and South East Asian operations along with its technology sectors.
In September 2023 Darren Dye was named Chief Executive Officer of ORANGEinfinity after a long career as CEO of the Pharmacy Alliance Group, the largest Independent Pharmacy business in Australia.
As of 2023, the firm had four main business units: OI Health, OI Technology, OI Retail, and OI distribution, the latter of which includes the AMA business acquired by ORANGEinfinity in 2023. All four units are supported by OI Treasury and Technology Services, which manages the group’s liquidity and financial investments.
Darren Dye serves as the ORANGEinfinity Chief Executive Officer (CEO), while founder Xing Mao serves as Executive Director.